Back
Phathom Pharmaceuticals Vs. Equifax Industry Stock Comparison
Buy
51
PHAT
Phathom Pharmaceuticals
Last Price:
9.26
Seasonality Move:
-5.3%
Buy
58
EFX
Equifax
Last Price:
220.78
Seasonality Move:
3.45%
Buy
51
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $9.26. The Score for PHAT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $220.67. The Score for EFX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $9.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight buying pressure.
EFX Stock Price Chart
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 45.41 | Sell |
Chaikin Money Flow: | 12452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
EFX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.5 | Sell |
Relative Strength Index (14 RSI): | 32.85 | Sell |
Chaikin Money Flow: | -394075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.76 - 257.44) | Sell |
Bollinger Bands (100): | (235.19 - 262.33) | Sell |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.14 | Buy |
20-day SMA: | 9.95 | Sell |
50-day SMA: | 9.8 | Sell |
200-day SMA: | 10.07 | Sell |
8-day EMA: | 9.27 | Sell |
20-day EMA: | 9.57 | Sell |
50-day EMA: | 9.48 | Sell |
200-day EMA: | 9.7 | Sell |
EFX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 223.15 | Sell |
20-day SMA: | 235.64 | Sell |
50-day SMA: | 252.36 | Sell |
200-day SMA: | 221.7 | Sell |
8-day EMA: | 224.26 | Sell |
20-day EMA: | 233.33 | Sell |
50-day EMA: | 243.24 | Sell |
200-day EMA: | 230.59 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Phathom Pharmaceuticals Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Equifax Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |